Recent Developments in Combination Immunotherapy with Other Therapies and Nanoparticle-Based Therapy for Triple-Negative Breast Cancer (TNBC) is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH/NIGMS
Grant: #1 R16GM145483-01
NIH/NIGMS
Grant: #1 C06 RR 020608-01
NIH/NIGMS
Grant: #1 C06 RR 14469-01
NIGMS NIH HHS
Grant: R16 GM145483
NIH HHS
Grant: 1R16GM145483-01,
National Institutes of Health
Grant: 1C06RR020608-01
EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM: REN*: PHARMACOLOGY
National Institutes of Health
Grant: 1R16GM145483-01
Multifunctional Nanotechnology Platform for Triple Negative Breast Cancer Treatment
FWCI
3.23
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals